US 8012490
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 8012490 (Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61P, A61P37/04